Farmakokinetikens Praktiske Konsekvenser: Belyst Ved Lithiumbehandlingens Styrings- Og Kontrolproblemer

Referencer

• Amdisen A. Serum lithium determinations for clinical use. Scand. J. clin. Lab. Invest. 1967; 20, 10: 4–108
   Web of Science ®Google Scholar
• Amdisen A., Schou M. Biochemistry of depression. Lancet 1967; 1
   Google Scholar
• Amdisen A., Sj J., ögren. Lithium absorption from sustained-release tablets (Duretter). Acta Pharm. Suec. 1968; 5
   PubMedGoogle Scholar
• Amdisen A. Variation of serum lithium concentration during the day in relation to treatment control, absorptive side effects and the use of slow-release tablets. Acta Psychiat. Scand., Suppl. 1969; 207
   Google Scholar
• Amdisen A., Eaastrup P. C., Schou M. Lithiumbehandling. Månedsskr. prakt. Lægegern. 1969; 47, 33: 7–353
   Google Scholar
• Amdisen A., Skjoldborg H. Haemodialysis for lithium poisoning. Lancet 1969; 1
   Google Scholar
• Amdisen A., Cottfries C. G., Jacobsson L., Winblad B. Svår lithiumförgiftning med dödlig utgång. Nord. Psykiat. T. 1973; 27, 53: 9–550
   Google Scholar
• Amdisen A. Serum lithium estimations. Brit. med. J. 1973; 2, 24: 0
   Google Scholar
• Amdisen A. The estimation of lithium in urine. I. Lithium Research and Therapy, F. N. Johnson. Academic Press, London 1975a
   Google Scholar
• Amdisen A. Sustained release preparations of lithium. Lithium Research and Therapy, F. N. Johnson. Academic Press, London 1975b
   Google Scholar
• Baastrup P. C. The use of lithium in manic-depressive psychosis. Comprehens. Psychiat. 1964; 5
   PubMed Web of Science ®Google Scholar
• Baastrup P. C., Schou M. Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis. Arch. gen. Psychiat. 1967; 16, 16: 2–172
   Google Scholar
• Baastrup P. C., Poulsen J. C., Schou M., Thomsen K., Amdisen A. Prophylactic lithium: Double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970; II
   Google Scholar
• Baastrup P. C. Practical problems concerning lithium maintenance therapy. Advances in Neuro-Psychopharmacology, O. Vinar, Z. Votava, P. B. Bradley. North-Holland Publ. Co., Amsterdam 1971
   Google Scholar
• Cade J. F. J. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 1949; 3
   Google Scholar
• Coppen A., Bailey J. E., White S. G. Slow-release lithium carbonate. J. clin. Pharmacol. 1969; 9
   Web of Science ®Google Scholar
• Coppen A., Noguera R., Bailey J., Burns B. H., Swani M. S., Hare E. H., Gardner R., Maggs R. Prophylactic lithium in affective disorders. Controlled trial. Lancet 1971; II
   Google Scholar
• Geisler A. Svigtende overholdelse af behandlingen som fejlkilde ved bedømmelse af et antidepressivums (amitriptylin) effekt ved reaktive depressioner. Nord. Psykiat. T. 1970; 24
   PubMedGoogle Scholar
• Hartigan G. P. The use of lithium salts in affective disorders. Brit. J. Psychiat. 1963; 109
   PubMed Web of Science ®Google Scholar
• Hollister L. E. Clinical use of psychoterapeutic drugs. Charles C. Thomas Publisher, Springfield, Illinois 1973
   Google Scholar
• Johnson D. A. W. The prophylaxis of manic-depressive psychosis. A study of lithium carbonate. Clin. Trial J. 1972; 9
   Google Scholar
• Kukopulos A., Reginaldi D. Personlig meddelelse 1974
   Google Scholar
• Marussek N., v. Hessling P. Vergleich von Lithium-Nebenwirkungen zwischen einem Kurzzeit- (Quilonum) und einem Depotpräparat (Lithium Duriles). Nervenarzt 1971; 42, 37: 6–378
   Google Scholar
• Meller-Nielsen I., Jergensen A., Fredricson-Overø K., Nymark M., Franck K. F. Farmakologiske og farmakokinetiske aspekter ved depot- og retardpræparater. Nord. Psykiat. T. 1971; 25
   Google Scholar
• Noack C. H., Trautner E. M. The lithium treatment of maniacal psychosis. Med. J. Aust. 1951; 38, 21: 9
   Google Scholar
• Rafaelsen O. J. Manic-depressive psychosis or manic-melancholic mode. Dan. med. Bull. 1974; 21
   Google Scholar
• Regårdh C.-G. Farmakokinetik. Apotekarsocieteten & Hässle Läkemedel, Göteborg 1973
   Google Scholar
• Schou M., Juel-Nielsen N., Stromgren E., Voldby H. The treatment of manic psychoses by the administration of lithium salts. J. Neurol. Neurosurg. Psychiat. 1954; 17, 25: 0–259
   Web of Science ®Google Scholar
• Schou M., Juel-Nielsen N., Stromgren E., Voldby H. Behandling af maniske psykoser med lithium. Ugeskr. Læg. 1955; 117, 9: 3–101
   Google Scholar
• Schou M. Die Lithiumprophylaxe bei manisch-depressiven Psychosen. Nervenarzt 1971; 42
   PubMedGoogle Scholar
• Schou M., Amdisen A., Baastrup P. C. The practical management of lithium treatment. Brit. J. Hosp. Med. 1971; 6, 5: 3–60
   Google Scholar
• Schou M., Shaw D. M. Lithium in recurrent manic-depressive disorder. Practitioner 1973; 210
   PubMedGoogle Scholar
• Schou M. Preparations, dosage and control. Lithium. Its Role in Psychiatric Research and Treatment, S. Gershon, B. Shopsin. Plenum, New York and London 1973
   Google Scholar
• Schou M. Current status of lithium therapy in affective disorders and other diseases. Foredrag holdt ved First Canadian International. Symposium on Lithium, Quebec, May 24, (publiceres) 1974
   Google Scholar
• Strömgren E., Schou M. Lithium treatment of manic states. Postgrad. Med. 1964; 35, 8: 3–86
   Google Scholar
• Talbott J. H. Use of lithium salts as a substitute for sodium chloride. Arch. Int. Med. 1950; 85
   Google Scholar
• Thomsen K., Schou M. Renal lithium excretion in man. Amer. J. Physiol. 1968; 215, 82: 3–827
   Google Scholar
• Thomsen K., Schou M. Treatment of lithium poisoning. Lithium Research and Therapy, F. N. Johnson. Academic Press, London 1975
   Google Scholar